Current Dosing of Oncology Drugs is Unnecessarily High and Needs Revision, Says Report

Using outmoded dosing structures, oncologists may be giving patients unnecessarily high doses of cancer meds, which provides no added benefit to the patient and, in fact, causes unnecessary side effects. The answer? More trials in oncology.
Source: Drug Industry Daily